» Articles » PMID: 24495582

Developing Core Outcomes Sets: Methods for Identifying and Including Patient-reported Outcomes (PROs)

Overview
Journal Trials
Publisher Biomed Central
Date 2014 Feb 6
PMID 24495582
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Synthesis of patient-reported outcome (PRO) data is hindered by the range of available PRO measures (PROMs) composed of multiple scales and single items with differing terminology and content. The use of core outcome sets, an agreed minimum set of outcomes to be measured and reported in all trials of a specific condition, may improve this issue but methods to select core PRO domains from the many available PROMs are lacking. This study examines existing PROMs and describes methods to identify health domains to inform the development of a core outcome set, illustrated with an example.

Methods: Systematic literature searches identified validated PROMs from studies evaluating radical treatment for oesophageal cancer. PROM scale/single item names were recorded verbatim and the frequency of similar names/scales documented. PROM contents (scale components/single items) were examined for conceptual meaning by an expert clinician and methodologist and categorised into health domains. A patient advocate independently checked this categorisation.

Results: Searches identified 21 generic and disease-specific PROMs containing 116 scales and 32 single items with 94 different verbatim names. Identical names for scales were repeatedly used (for example, 'physical function' in six different measures) and others were similar (overlapping face validity) although component items were not always comparable. Based on methodological, clinical and patient expertise, 606 individual items were categorised into 32 health domains.

Conclusion: This study outlines a methodology for identifying candidate PRO domains from existing PROMs to inform a core outcome set to use in clinical trials.

Citing Articles

Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review.

Delameillieure A, Somogyi V, Schenk S, Toreyin N, Stenzel N, Van Bulck L Eur Respir Rev. 2025; 34(175.

PMID: 39843158 PMC: 11751723. DOI: 10.1183/16000617.0133-2024.


Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis.

Lee N, Smith C, Bailey R, Ariyoshi K, Smith S, Black N Trials. 2025; 26(1):6.

PMID: 39762892 PMC: 11702042. DOI: 10.1186/s13063-024-08713-6.


The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.

Cruickshank M, Hudson J, Hernandez R, Aceves-Martins M, Quinton R, Gillies K Health Technol Assess. 2024; 28(43):1-210.

PMID: 39248210 PMC: 11404359. DOI: 10.3310/JRYT3981.


Laparoscopic cholecystectomy versus conservative management for adults with uncomplicated symptomatic gallstones: the C-GALL RCT.

Innes K, Ahmed I, Hudson J, Hernandez R, Gillies K, Bruce R Health Technol Assess. 2024; 28(26):1-151.

PMID: 38943314 PMC: 11228691. DOI: 10.3310/MNBY3104.


Developing a core outcome set for acetabular fractures: a systematic review protocol.

Schulz D, Deichsel A, Jordan M, Windolf J, Raschke M, Neubert A Syst Rev. 2024; 13(1):150.

PMID: 38840193 PMC: 11151679. DOI: 10.1186/s13643-024-02571-8.


References
1.
Verschuur E, Steyerberg E, Kuipers E, Essink-Bot M, Tran K, van der Gaast A . Experiences and expectations of patients after oesophageal cancer surgery: an explorative study. Eur J Cancer Care (Engl). 2006; 15(4):324-32. DOI: 10.1111/j.1365-2354.2006.00659.x. View

2.
Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E . Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. PMC: 3472231. DOI: 10.1186/1745-6215-13-132. View

3.
Nakamura M, Kido Y, Egawa T . Development of a 32-item scale to assess postoperative dysfunction after upper gastrointestinal cancer resection. J Clin Nurs. 2008; 17(11):1440-9. DOI: 10.1111/j.1365-2702.2007.02179.x. View

4.
Parameswaran R, Blazeby J, Hughes R, Mitchell K, Berrisford R, Wajed S . Health-related quality of life after minimally invasive oesophagectomy. Br J Surg. 2010; 97(4):525-31. DOI: 10.1002/bjs.6908. View

5.
Courrech Staal E, van Sandick J, van Tinteren H, Cats A, Aaronson N . Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. J Thorac Cardiovasc Surg. 2010; 140(4):777-83. DOI: 10.1016/j.jtcvs.2010.05.018. View